This clinical trial is currently not recruiting patients.
Register to get notified for future clinical trials.
See other Clinical Trials
Share: Email

Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Clinical Trial stock photo

Complete the Trial Form Below:

Check eligibility to participate in the study

  • Enter your zip code

    We'll show you investigators/research sites in this zip.

  • We will contact upto 3 sites within 100 Miles

Qualification Message

Unfortunately, you did not qualify for this study. See details

You may qualify for a future study, please enter your contact information below to get notified.

  • Enter your name

  • Your email helps investigators to follow up with you.

  • Your phone number helps investigators to follow up with you.

  • By clicking this button you agree to our privacy and terms of service policies. Your information is kept completely confidential and shared only with the clinical trial personnel.
Saved Successfully

Your information has been saved successfully. We will notify you incase a matching trial comes up

You might also be interested in other clinical trials in your area







Select Investigators or Research Sites to contact
  • We will contact upto 3 sites within 100 Miles
Send Message to Investigator
  • Enter your name

  • Your email helps investigators to follow up with you.

  • Your phone number helps investigators to follow up with you.

  • Click to see the preview of your message

  • By clicking this button you agree to our privacy and terms of service policies. Your information is kept completely confidential and shared only with the clinical trial personnel.

Study Description

You may be eligible for this study if you meet the following criteria:

  • Conditions: Diabetes Mellitus, Type 2
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • +
    Inclusion Criteria:
  • +
    Exclusion Criteria:

Participation Details

The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to Placebo during long term treatment (52 weeks and longer) in combination with basal insulin in patients with type 2 diabetes mellitus with insufficient glycaemic control.

Additional Information

Clinical Trial Identifier: TX89686

Trial open to limited number of participants
81 users have viewed this page
Need Help?Contact us

Send a Message to TrialX

Your Email:
Your Phone:
Your Message:
   
To Email:
Your Email:
Your Name:
Your Message:
   
Not interested in this trial? Register to get notified for future clinical trials.